The reliability of sampling three to six nodes for staging breast cancer

Journal of Clinical Pathology

Volumn 52, Issue 9, 1999, Pages 681-683

  Cserni, Gábor ^a  

^a BÁCS KISKUN COUNTY TEACHING HOSPITAL   (Hungary)

Author keywords

Axillary clearance; Axillary sampling; Breast cancer

Indexed keywords

ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER STAGING; HUMAN; HUMAN TISSUE; LYMPH NODE BIOPSY; ORGAN SIZE; PRIORITY JOURNAL; QUANTITATIVE HISTOCHEMISTRY; SAMPLING; UNITED KINGDOM;

EID: 0032832365     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.52.9.681     Document Type: Article

References (28)

1. Fisher B, Wolmark N, Bauer M, et al. The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast. Surg Gynecol Obstet 1981;152:765-72.
2. Danforth DN, Findlay PA, McDonald HD, et al. Complete axillary lymph node dissection for stage I Il carcinoma of the breast. J Clin Oncol 1986;4:655-62.
3. McLean RG, Ege GN. Prognostic value of axillary lymphoscintigraphy in breast carcinoma patients. J Nucl Med 1986;27:1116-24.
4. Crowe JP, Lee MD, Adler MD, et al. Positron emission tomography and breast masses: comparison with clinical, mammographic, and pathological findings. Ann Surg Oncol 1094;1:132-40.
5. Tate J, Lewis V, Archer T, et al. Ultrasound detection of axillary lymph node metastases in breast cancer. Eur J Surg Oncol 1989;15:139-42.
6. Forrest APM, Roberts MM, Cant E, et al. Simple mastectomy and pectoral node biopsy. Br J Surg 1976;63:569-75.
7. Kjaergaard J, Blichert-Toft M, Andersen JA, et al, and the Danish Brcast Cancer Cooperative Group. Probability of false negative nodal staging in conjunction with partial axillary dissection in breast cancer, Br J Surg 1985;72:365-7.
8. Steele RJC, Forrest APM, Gibson T, et al. The efficacy of lower axillary sampling in obtaining lymph node status in breast cancer; a controlled randomised trial. Br J Surg 1985;72:368-9.
9. Fisher CJ, Boyle S, Burke M, et al. Intraoperative assessment of nodal status in the selection of patients with breast cancer for axillary clearance, Br J Surg 1993;80:457-8.
10. Greenall MJ. Why I favour axillary node sampling in the management of breast cancer, Eur J Surg Oncol 1995;21:2-5.
11. Krag DN, Weaver DI, Alex JC, et al. Surgical resection and radiolocalization of sentinel lymph node in breast Cancer using a gamma probe. Surg Oncol 1993;2:335-40.
12. Giuliano AE, Kirgan DM, Guenther JM, et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391-401.
13. Albertini JJ, Lyman GH, Cox C, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 1996;276:1818-22.
14. Veronesi U, Paganelli G, Galimberti V, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 1997;349:1864-7.
15. Davies GC, Millis RR, Hayward JL. Assessment of axillary lymph node status, Ann Surg 1980;192:148-151.
16. Kissin MW, Thompson PH, Price AB, et al. The inadequacy of axillary sampling in breast cancer. Lancet 1982;i:1210-12.
17. Pigott J, Nichols MD, Maddox WA, et al. Metastases to the upper levels of axilllary nodes in carcinoma of the breast and its implications for nodal sampling procedures. Surg Gynecol Obstet 1984;158:255-9.
18. Mathiesen O, Carl J, Bonderup O, et al. Axillary sampling and the risk of erroneous staging of breast cancer. Acta Oncol 1990;29:721-5.
19. Kinne DW. Controversies in primary breast cancer management. Am J Surg 1993;166:502-8.
20. Davidson T. Why I favour axillary node clearance in the management of breast cancer, Eur J Surg Oncol 1995;21:5-7.
21. Spiessl B, Beahrs OH, Hermanek P, et al, eds. Breast tumours. In: UICC TNM atlas. Berlin: Springer-Verlag, 1990:173-83.
22. Kiricuta CI, Tausch J. A mathematical model of axillary lymph node involvement based on 1446 complete axillary dissections in patients with breast carcinoma. Cancer 1992;69:2496-501.
23. Cserni G. Changing trends in lymph node recovery from axillary clearance specimens in breast cancer: possible implications for the quantitative axillary status from a 17 year retrospective study Eur J Oncol 1907;2:403-8.
24. Cserni G. How to improve low lymph node recovery rates from axillary clearance specimens of breast cancer? A short-term audit. J Clin Pathol 1998;51:846-9.
25. Cserni G. Estimating the overlap between sentinel lymph nodes and axillary node samples in breast cancer. Pathol Oncol Res 1999;5:129-33.
26. Macmillan RD, Hadjiminas D, Barbera D, et al. Sentinel node biopsy and axillary node sampling how they compare. Eur J Surg Oncol 1998;24:618.
27. Statman R, Giuliano AE. The role of the sentinel lymph node in the management of patients with breast cancer. Adv Surg 1997;30:209-21.
28. Kingston RD, Bridget J, Smith CJ, et al. Axillary sampling and radiotherapy does nor compromise the patient with early breast cancer: Trafford database experience. Eur J Surg Oncol 1995;21:364-7.